Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 3/20 | 1.00 |
| ▸ | MTNR1A | P48039 | 6/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HTR6 | P50406 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10312248 | 0.83 | NQO2 (0.71) | NQO2KEAP1CA2CA12CA1 | |
| SCHEMBL31594624 | 0.83 | NQO2 (0.71) | NQO2KEAP1CA2CA12CA1 | |
| SCHEMBL8858490 | 0.81 | NQO2 (0.68) | NQO2MTNR1ACA2HTR6HPGD | |
| SCHEMBL5609972 | 0.77 | NQO2 (0.63) | NQO2MTNR1AKEAP1CA2 | |
| SCHEMBL606293 | 0.77 | MTNR1A (0.63) | NQO2MTNR1AHPGDHTT | |
| SCHEMBL8794788 | 0.76 | HPGD (0.64) | NQO2MTNR1ACA2HPGDCA12 | |
| SCHEMBL8883022 | 0.76 | NQO2 (0.61) | NQO2MTNR1AHTR6 | |
| SCHEMBL3295201 | 0.76 | NQO2 (0.61) | NQO2MTNR1ACA2POLBHPGD | |
| SCHEMBL5725032 | 0.76 | NQO2 (0.61) | NQO2CA2POLBCA12CA1 | |
| Hydrochloric Acid SCHEMBL27581438 | 0.75 | MTNR1A (0.61) | NQO2MTNR1AHPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120174324-A1 | DYES FOR POLYMER COLORATION, THEIR PREPARATION AND THEIR USE | DYSTAR COLOURS DEUTSCHLAND GMBH (DE) | 2012-07-12 | — | — | US | disclosed |
| US-8138218-B2 | Growth hormone secretagogues | IPSEN PHARMA S.A.S. (FR) | 2012-03-20 | — | — | US | disclosed |
| US-20090131478-A1 | Growth Hormone Secretagogues | IPSEN PHARMA S.A.S. (FR) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131478-A1 | Growth Hormone Secretagogues | GHSR, GHRHR, GHITM | NQO2 3273/4885MTNR1A 478/4885KEAP1 4496/4885 |
| US-20120174324-A1 | DYES FOR POLYMER COLORATION, THEIR PREPARATION AND THEIR USE | IK, H1-0, H1-5 | NQO2 390/4885MTNR1A 2622/4885KEAP1 2728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.